Intangible Assets

QSI does not show evidence of durable brand, proprietary IP, or regulatory exclusivity in the provided metrics, so it lacks the kind of protected asset base that would sustain pricing power versus peers.

Negative ROIC and ROCE indicate that any intangible advantage is not translating into excess returns, which is weaker than peers with proven monetizable IP or clinical franchises.

The absence of disclosed 5-year profitability and margin history in the provided data limits support for a durable intangible moat, while stronger peers typically show repeatable margin capture from protected assets.

In a peer comparison, QSI appears more like a development-stage or early-commercial company than a company with entrenched intangible assets that lock in customers or reimbursement.

Switching Costs

The provided metrics do not indicate installed-base lock-in, workflow dependence, or contractual frictions, so customers appear able to switch without material economic penalty versus peers with embedded platforms.

Very low asset turnover and deeply negative ROIC suggest the business is not yet monetizing a sticky customer base, which is inconsistent with meaningful switching costs.

There is no evidence in the supplied data of recurring consumables, software integration, or regulated process dependence that would raise retention relative to peers.

Compared with peers that benefit from recurring usage or high integration costs, QSI’s current financial profile does not support durable switching-cost protection.

Network Effects

The supplied information does not show user-to-user, data, or ecosystem feedback loops, so there is no clear mechanism for network effects to compound versus peers.

Negative returns and minimal asset productivity are inconsistent with a platform that becomes more valuable as adoption rises.

No evidence is provided of a dominant data advantage, marketplace liquidity, or partner ecosystem that would make QSI increasingly hard to displace.

Relative to peers with strong network-driven adoption, QSI currently appears to have little structural benefit from scale in usage.

Cost Advantage

QSI’s negative ROIC and ROCE imply that it is not converting operations into a cost position that beats peers, which argues against a durable cost advantage.

The extremely low asset turnover suggests weak operating efficiency, so the company does not appear to have a structural cost edge from asset utilization.

No evidence is provided of proprietary manufacturing, scale purchasing, or process advantages that would lower unit costs versus peers.

Against peers with established production scale or lower-cost distribution, QSI’s current metrics point to a weaker rather than stronger cost position.

Efficient Scale

The available data do not indicate that QSI serves a niche large enough to support efficient-scale protection, so competition is unlikely to be structurally constrained versus peers.

Negative returns suggest the company has not yet reached a scale point where fixed costs are spread enough to create a durable advantage.

There is no evidence of regulated capacity limits, exclusive access to scarce assets, or a natural monopoly structure that would deter peer entry.

Compared with peers that benefit from concentrated demand or high fixed-cost barriers, QSI does not currently show efficient-scale characteristics.

Overall Score

QSI currently shows no clear evidence of a durable economic moat versus peers, because the provided metrics point to negative capital returns, weak operating efficiency, and no visible structural support from intangible assets, switching costs, network effects, cost advantage, or efficient scale.